Score Pharma, Inc.
↗Huntsville, AL, USA
Score Pharma is a virtual, early-stage biotechnology company that leverages its proprietary CoreX technology to develop second-generation, ADCC-enhanced monoclonal antibody (mAb) therapeutics. By introducing small structural changes during the upstream biologics production process, the company aims to improve the cancer-killing mechanism of existing, clinically validated antibody therapies.
The company operates as a virtual biotech, utilizing strategic partnerships and distributed resources, with a presence at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama, and Southern Research in Birmingham, Alabama. Its primary focus is on oncology, specifically targeting HER2-positive breast cancer, with potential applications in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:gBETA, The Innovation Space
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:mAb
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:HudsonAlpha Institute for Biotechnology (location/ecosystem), Southern Research (scientific confirmation studies)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Bruce Edward Jones - Founder, President, and CEO
Jennifer Riggs-Sauthier - Chief Development Officer & VP of Chemistry
Martina Molsbergen - Co-Founder / VP - Business Development
Scientific Founders:Bruce Edward Jones
Board Members:Steven Feder
LINKS
Website:scorepharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Score Pharma, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Score Pharma, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.